US equities |

Deep Endometriosis Organ Spread Symptom Relief: Excision Surgery Guide Published

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Endometriosis rarely stays in one place, and when it reaches the bowel, bladder, or diaphragm, the surgical stakes change. Lotus Endometriosis Institute has released a new guide detailing what that kind of surgery actually requires.

-- Lotus Endometriosis Institute, a leading California-based surgical practice, has published a guide to excision surgery for deep or multi-organ endometriosis, written to help patients weigh their surgical options when disease extends beyond the pelvis to the bowel, bladder, ureters, pelvic nerves, or diaphragm.

More information is available at https://lotusendo.com/procedures/endometriosis-excision-surgery

The World Health Organization estimates that endometriosis affects about 10 percent of reproductive-age women worldwide, roughly 190 million people. For patients whose disease reaches beyond the pelvic lining, the choice of surgery, and of surgeon, becomes a defining part of care. Lotus Endometriosis Institute designed its guide to make that choice clearer.

The institute regards excision as the gold standard surgical approach for many patients. Excision removes endometriosis from its root down to healthy tissue, rather than treating only the surface, and it allows tissue confirmation of the diagnosis. The clinical team points to stronger evidence for excision in endometriomas and deeper disease, where complete removal is associated with more durable pain relief and lower recurrence.

The resource is organized around the questions patients ask when choosing a path: when surgery is recommended, what the operation involves, what recovery looks like, and how to judge a surgeon's experience with complex disease. It also covers minimally invasive and robotic-assisted approaches, the role of additional surgical specialists when the bowel or urinary tract is involved, and how supportive care fits around surgery.

Experience matters because multi-organ disease can be subtle and sits close to structures where precision is critical. Lotus Endometriosis Institute's surgical team is led by Dr. Steven Vasilev, a quadruple board-certified surgeon described by the institute as an early adopter of advanced excision techniques before the term minimally invasive gynecologic surgery, or MIGS, was coined.

"Patients with multi-organ disease deserve to understand their options before they ever reach an operating room," said Dr. Vasilev. "Thorough excision by an experienced surgeon can offer meaningful, longer-lasting relief for many patients, and this guide is meant to help them recognize what that looks like."

About Lotus Endometriosis Institute

At Lotus Endometriosis Institute, excision surgery forms part of a broader care approach that can include advanced diagnostic evaluation, pain-focused support and integrative recovery care.

Additional information about Lotus Endometriosis Institute and its individualized treatment planning for complex endometriosis is available at https://lotusendo.com

Contact Info:
Name: Dr. Steven Vasilev
Email: Send Email
Organization: Lotus Endometriosis Institute
Address: 154 Traffic Way, Arroyo Grande, CA 93420, United States
Website: https://lotusendo.com

Source: PressCable

Release ID: 89208503

Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  260.21
-5.82 (-2.19%)
AAPL  344.17
-5.34 (-1.53%)
AMD  404.40
-84.38 (-17.26%)
BAC  49.76
-1.87 (-3.62%)
GOOG  281.74
-5.56 (-1.94%)
META  605.08
-24.92 (-3.96%)
MSFT  535.93
-19.87 (-3.58%)
NVDA  181.60
-18.53 (-9.26%)
ORCL  115.16
-8.57 (-6.93%)
TSLA  343.69
-41.50 (-10.77%)